Noile-Immune Biotech (TSE:4893) EPS (Basic) : 円-22.01 (TTM As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech EPS (Basic)?

Noile-Immune Biotech's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was 円0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was 円-22.01.

Noile-Immune Biotech's EPS (Diluted) for the three months ended in Dec. 2024 was 円0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was 円-22.64.

Noile-Immune Biotech's EPS without NRI for the three months ended in Dec. 2024 was 円0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was -22.64.

During the past 3 years, the average EPS without NRI Growth Rate was -4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Noile-Immune Biotech's highest 3-Year average EPS without NRI Growth Rate was -4.80% per year. The lowest was -24.60% per year. And the median was -14.70% per year.

Noile-Immune Biotech EPS (Basic) Historical Data

The historical data trend for Noile-Immune Biotech's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech EPS (Basic) Chart

Noile-Immune Biotech Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

-15.48

-19.34

-9.87

-27.25

-22.28

Noile-Immune Biotech Quarterly Data
	Dec20	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24
EPS (Basic)	Get a 7-Day Free Trial						0.22	-6.44	-7.86	-7.93	-

Noile-Immune Biotech EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Noile-Immune Biotech's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-964.455	-	0)	/	43.288
	=	-22.28

Noile-Immune Biotech's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(0	-	0)	/	43.288
	=	0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-22.01

Noile-Immune Biotech (TSE:4893) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Noile-Immune Biotech EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Noile-Immune Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012

Website

https://www.noile-immune.com

Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech Headlines

No Headlines